BioCentury
ARTICLE | Company News

Lorus, Brock University deal

December 24, 2012 8:00 AM UTC

Lorus partnered with the university to develop cancer drugs based on chemical derivatives of pancratistatin, a natural compound. Lorus will be responsible for testing the anticancer activity and drug-...